<?xml version="1.0" ?>
<document id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78">
  <chunk id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c0" text="Placement of Leucine Zipper Motifs at the Carboxyl Terminus of HIV-1 Protease Significantly Reduces Virion Production">
    <entity charOffset="13-20" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c0.e0" ontology_id="CHEBI_15603" text="Leucine" type="chemical"/>
    <entity charOffset="13-20" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c0.e1" ontology_id="CHEBI_25017" text="Leucine" type="chemical"/>
  </chunk>
  <chunk id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1" text="Natural HIV-1 protease (PR) is homodimeric. Some researchers believe that interactions between HIV-1 Gag-Pol molecules trigger the activation of embedded PR (which mediates Gag and Gag-Pol cleavage), and that Gag-Pol assembly domains outside of PR may contribute to PR activation by influencing PR dimer interaction in a Gag-Pol context. To determine if the enhancement of PR dimer interaction facilitates PR activation, we placed single or tandem repeat leucine zippers (LZ) at the PR C-terminus, and looked for a correlation between enhanced Gag processing efficiency and increased Gag-PR-LZ multimerization capacity. We found significant reductions in virus-like particles (VLPs) produced by HIV-1 mutants, with LZ fused to the end of PR as a result of enhanced Gag cleavage efficiency. Since VLP production can be restored to wt levels following PR activity inhibition, this assembly defect is considered PR activity-dependent. We also found a correlation between the LZ enhancement effect on Gag cleavage and enhanced Gag-PR multimerization. The results suggest that PR dimer interactions facilitated by forced Gag-PR multimerization lead to premature Gag cleavage, likely a result of premature PR activation. Our conclusion is that placement of a heterologous dimerization domain downstream of PR enhances PRmediated Gag cleavage efficiency, implying that structural conformation, rather than the primary sequence outside of PR, is a major determinant of HIV-1 PR activation.">
    <entity charOffset="109-118" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e0" ontology_id="CHEBI_25367" text="molecules" type="chemical"/>
    <entity charOffset="173-176" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e1" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
    <entity charOffset="455-462" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e2" ontology_id="CHEBI_15603" text="leucine" type="chemical"/>
    <entity charOffset="455-462" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e3" ontology_id="CHEBI_25017" text="leucine" type="chemical"/>
    <entity charOffset="544-547" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e4" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
    <entity charOffset="765-768" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e5" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
    <entity charOffset="997-1000" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e6" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
    <entity charOffset="1157-1160" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e7" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
    <entity charOffset="1323-1326" id="3e035bd3c87d15ec4bca05cd13551c70d1bc5e78.c1.e8" ontology_id="CHEBI_143889" text="Gag" type="chemical"/>
  </chunk>
</document>
